Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07396610Completed
Randomised, double-blind trial of calcium sodium phosphosilicate in Dentinal hypersensitivity (DH) (3 arms), sponsored by King Khalid University. Primary endpoint: Change in Dentinal Hypersensitivity Pain at 12 months. Started Jan 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07396610.